Chinesische Frau Qiu Qiong, wer ist der erste Impfstoff, der Empfänger mit einer Quadrivalent Human Papilloma Virus (HPV) Impfstoff gegen Gebärmutterhalskrebs geimpft zu werden.
Chinese woman Qiu Qiong, who is the first vaccine recipient to be inoculated with a quadrivalent human papilloma virus (HPV) vaccine against cervical cancer, receives the vaccination at the Obstetrics and Gynecology Hospital affiliated to the Fudan University in Shanghai, China, 8 March 2018. In a major step forward in fighting cervical cancer, a human papilloma virus (HPV) vaccine was made available in China for people under the age of 45 on Thursday (8 March 2018). Cervical cancer is caused by sexually acquired infection with certain types of HPV, with types 16 and 18 causing 70 percent of all cervical cancers. There is also evidence linking HPV with other cancers affecting both male and female genitals. Cervical cancer is the second most common cancer among women, after breast cancer, with almost 530, 000 new cases reported worldwide every year. China has a very high incidence and death rate, with around 98, 900 new cases reported in 2015 and 30, 500 deaths. In other words, three Chinese women died of cervical cancer every hour. Qiu Qiong, 35, a mother of two boys, was the first vaccine recipient at the Obstetrics and Gynecology Hospital affiliated to the Fudan University. Her mother died of cervical cancer seven years ago. "I would never forget my mother's pain and despair in her last days, " said Qiu. "I wanted to get the vaccination immediately."
